Table 4: Prognostic factors of death by multiple cox proportional hazard regression (n = 124).
Covariates |
ACT |
NACT* |
||||||
Adj. β |
Adj. HR (95% CI) |
Wald statistic |
p-value |
Adj. β |
Adj. HR (95% CI) |
Wald statistic |
p-value |
|
Age < 50 years ≥ 50 years |
0 2.070 |
Referent 7.93 (0.91-18.84) |
3.52 |
0.061 |
0 0.399 |
Referent 1.49 (0.46-4.85) |
0.438 |
0.508 |
Ethnic Malay Non-Malay |
0 0.037 |
Referent 1.04 (0.35-3.13) |
0.04 |
0.947 |
0 0.535 |
Referent 1.70 (0.41-7.25) |
0.527 |
0.468 |
Stage Early stage Advanced stage |
0 2.412 |
Referent 11.16 (2.15-37.90) |
8.23 |
0.004 |
|
- - |
- - |
- - |
Molecular subtypes Luminal A TNBC Other |
0 1.255 1.170 |
Referent 1.84 (1.24-2.94) 1.78 (1.14-4.20) |
0.08 0.07
|
0.767 0.790
|
0 0.511 0.497 |
Referent 1.60 (0.96-6.52) 1.64 (0.90-6.72) |
0.176 0.479 |
0.675 0.489 |
Chemotherapy Anthracycline based Taxane based Antharacycline+Taxane |
0 2.213 -1.577 |
Referent 6.15 (1.38-10.54) 0.21 (0.04-1.04) |
5.77 3.67 |
0.022 0.049 |
0 0.224 1.377 |
Referent 1.15 (0.82-6.21) 0.96 (0.52-5.34) |
0.063 0.097 |
0.802 0.796 |
Schedule modification No Modification With Modification |
0 0.266 |
Referent 1.31 (0.31-5.52) |
0.13 |
0.718 |
0 0.214 |
Referent 1.23 (0.42-3.67) |
0.149 |
0.699 |
*NACT: Covariate stage was excluded from multivariate analysis as no death was observed among early stage patients.